ERECTAZINE Trademark

Trademark Overview


On Monday, August 7, 2023, a trademark application was filed for ERECTAZINE with the United States Patent and Trademark Office. The USPTO has given the ERECTAZINE trademark a serial number of 98120532. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, May 9, 2024. This trademark is owned by Sarak Bioceuticals LLC. The ERECTAZINE trademark is filed in the Pharmaceutical Products category with the following description:

Nutraceuticals for the treatment of Erectile complications
erectazine

General Information


Serial Number98120532
Word MarkERECTAZINE
Filing DateMonday, August 7, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, May 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesNutraceuticals for the treatment of Erectile complications

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 6, 2023
Primary Code005
First Use Anywhere DateSunday, January 1, 2023
First Use In Commerce DateSunday, January 1, 2023

Trademark Owner History


Party NameSarak Bioceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFlowery Branch, GA 30542

Trademark Events


Event DateEvent Description
Thursday, August 10, 2023NEW APPLICATION ENTERED
Wednesday, September 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 8, 2024ASSIGNED TO EXAMINER
Thursday, May 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 9, 2024NON-FINAL ACTION WRITTEN
Thursday, May 9, 2024NON-FINAL ACTION E-MAILED